Abiopharma

🔍 Silverman Josh (Executive)

Company: ETSY INC (ETSY)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Common Stock at $10.62 per share (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 180,694.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 50,000 shares of Common Stock at $72.5 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 130,694.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 52,479 shares of Common Stock at $10.62 per share (Direct)
  Date: 2026-06-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 183,173.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 52,479 shares of Common Stock at $74.0 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 130,694.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By GST Trust | shares_owned_after: 4,942.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By Non-GST Trust | shares_owned_after: 16,886.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By Irrevocable Trust | shares_owned_after: 42,269.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By GRAT | shares_owned_after: 109,675.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: H | nature_of_ownership: By 2019 Trust | shares_owned_after: 54,325.00 | Footnotes: F5
• Sold 50,000 shares of Employee Stock Option (Right to Buy) at $10.62 per share (Derivative)
  Date: 2026-06-15 | Code: M | Expires: 2027-05-03 | equity_swap_involved: 0 | shares_owned_after: 369,876.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 52,479 shares of Employee Stock Option (Right to Buy) at $10.62 per share (Derivative)
  Date: 2026-06-16 | Code: M | Expires: 2027-05-03 | equity_swap_involved: 0 | shares_owned_after: 317,397.00 | transaction_form_type: 4 | Footnotes: F1, F6

Footnotes:

• F1: These exercises and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.
• F2: These shares are held by the JGS 2018 Irrevocable GST Trust (the "GST Trust"). The Reporting Person's spouse is the trustee of the GST Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F3: These shares are held by the JGS 2018 Irrevocable Non-GST Trust (the "Non-GST Trust"). The Reporting Person's spouse is the trustee of the Non-GST Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F4: These shares are held by a grantor retained annuity trust (the "GRAT"). The Reporting Person is the trustee and the beneficiary of the GRAT.
• F5: These shares are held by the Joshua G. Silverman 2019 Irrevocable Children's Trust (the "2019 Trust"). A family member of the Reporting Person is the trustee of the 2019 Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F6: These stock options are part of a grant that vested as to 25% on May 4, 2018 with the remainder vesting in 36 equal monthly installments.